FDA Issues Warning To Ista Over Misleading Sales Materials

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Wednesday, March 17, 2010

Comments

Ocular surgery News

The U.S. Food and Drug Administration has issued a warning letter to Ista Pharmaceuticals in reference to advertising materials used to market the drug Xibrom.

Full Story

Cataract Products and Equipment »

The majority of vision loss in diabetic patients is due to which of the following:
1. Cataract
2. Macular edema
3. Vitreous hemorrhage
4. Tractional retinal detachment
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

FDA Issues Warning To Ista Over Misleading Sales Materials

Comments

Related Categories

Cataract Products and Equipment »

Quick Quiz

The majority of vision loss in diabetic patients is due to which of the following:

AdGlare RMR Ad

Cataract Featured Products

CareCloud Central

OPMI LUMERA 700 Surgical Microscope

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us